Whitepapers

Decentralized Clinical Trial Regulations: A 2022 Report

Decentralization in clinical trials is quickly turning into a must-have for companies that truly want to support patients, provide more convenience and reach recruitment goals. Decentralized clinical trials (DCTs) hold the potential to reach new, remote patient populations, innovate rare and orphan disease research, and accelerate medical discovery.  In order …

Decentralized Clinical Trial Regulations: A 2022 Report Read More »

What is the patient journey of people actively looking for clinical trials?

“85% of clinical trials fail to recruit and retain enough patients in order to meet their enrollment timeline” – a number which we see quite often in analyses, publications, or events presentations within the clinical research industry. With one-third of study budgets going into patient recruitment and hundreds of experienced …

What is the patient journey of people actively looking for clinical trials? Read More »

Why High-Risk Patients Are Still Willing to Visit a Site Weekly?

At the beginning of this global lockdown, my colleagues and I had some assumptions, concerns and predictions about the impact of Covid-19 on clinical trials and more specifically – patient enrollment.  We anticipated a lot of worried patients who, themselves belonging to various risk groups, would be anxious to make …

Why High-Risk Patients Are Still Willing to Visit a Site Weekly? Read More »

Guidance on the Management of Clinical Trials during COVID-19: How Countries respond

2020 began with a surprise for many people, industries and governments. The coronavirus outbreak turned the world upside down and became a global threat the likes of which we hadn’t experienced for ages. Unfortunately, the clinical research industry was also impacted severely mostly due to the social distancing measures recommended …

Guidance on the Management of Clinical Trials during COVID-19: How Countries respond Read More »

Scroll to Top